Crinetics Pharmaceuticals, Inc. (CRNX)
35.20
-1.57
(-4.27%)
USD |
NASDAQ |
May 18, 12:55
Crinetics Pharmaceuticals Research and Development Expense (Quarterly) : 98.92M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 38.38M |
| Aquestive Therapeutics, Inc. | 4.204M |
| Merck & Co., Inc. | 11.98B |
| Nektar Therapeutics | 35.68M |
| Prestige Consumer Healthcare, Inc. | -- |